Elsevier Launches ExamPrep, New Medical Exam Preparation and Simulation Tool for Medical Students

LONDON, February 26, 2015 /PRNewswire/ --

Using adaptive learning technology, Elsevier's ExamPrep pre-tests students to customize the study experience and identify topics that need more focus

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the commercial launch of its new English language medical exam preparation and simulation tool, ExamPrep, across UK, Northern Europe and EMEA-LA.

In collaboration with Learning Objects, Inc., a leader in social software for learning, ExamPrep uses the latest adaptive technology to pre-test learners to formulate individual benchmarks. ExamPrep then presents questions and remediation content from Elsevier's most trusted sources - including Kumar & Clark's Cases in Clinical Medicine, Medical Sciences, and Gray's Anatomy for Students - based on their progress and performance. Students can also create their own learning plan, actively involving and engaging them in their own performance and development, as it moves them through their revision to achieve exam success.

"It makes the exam preparation experience more efficient and effective," said Rachel Armitage, e-Education Director, EMEA-LA, Elsevier Clinical Solutions. "Instead of students reviewing the same material over and over, ExamPrep customizes the study experience and identifies topics students need to focus on to achieve their learning outcomes."

At an institutional level ExamPrep allows faculty to create assignments from an extensive bank of questions or create questions with an author questioning tool. ExamPrep also provides analytics that enables faculty to monitor students' progress, assess exam readiness, identify topics that require further review and potentially adjust their teaching to deliver improved learning outcomes.

"Faculty are under increasing pressure to provide personalized learning to all students. That's not always possible, given large class sizes and time available," Armitage said. "ExamPrep helps to alleviate this demand as its performance dashboards include a robust set of metrics where faculty can see how their students are doing in mastering key concepts and intervene where necessary."

Incorporating Learning Objects' Difference Engine, Elsevier built ExamPrep on an adaptive assessment algorithm that takes into account learner mastery and established learning science.

"Medical education is a lifelong continuum of learning that starts at medical school," Armitage said. "ExamPrep incorporates modern learning theories, from the forgetting curve and spaced repetition to item response theory, to maximise the effectiveness of the learning experience and improve student performance."

Available offline and device agnostic, ExamPrep is just one of the many learning tools from Elsevier that supports the learning of tomorrow's doctors and healthcare professionals. ExamPrep is an English language eProduct available in the UK, Northern Europe and will roll out in EMEA-LA later this year.

For more information on ExamPrep, visit http://www.elsevierexamprep.co.uk/institutional.

About Learning Objects 

Learning Objects was founded in 2003 to bring collaboration and social learning technologies to education. It is a fast-growing, mission-driven start-up, owner-operated and privately held. Learning Objects serves over 300 leading education organizations under the Difference Engine, Campus Pack, and Learning Objects brands, inventing and delivering next-gen education technology products.

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 33,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-917-704-5174
c.capot@elsevier.com